ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2018

Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MS.

Elizabeth A Mills et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.